“…The reverse regulation pattern of down regulated non-adipogenic gene products (e.g. jagged 1, JAG1 correlated with osteogenesis (Nobta et al, 2005) and angiogenesis (Uyttendaele et al, 2000), CYR61 involved in angiogenesis (Lau and Lam, 1999;Schutze et al, 2005a), muscle-associated tropomyosin 1 (alpha), cysteine and glycine-rich protein 2, CSRP2, myosin heavy polypeptide 11 smooth muscle, and villin 2 A c c e p t e d M a n u s c r i p t -17 -(ezrin), VIL2 (MacLeod and Gooding, 1988;Louis et al, 1997;Babu et al, 2000;Moyen et al, 2004)) and up regulated adipogenesis-related gene products (C/EBPα, LPL and acetyl-CoA carboxylase β (Rosen et al, 2002;Wu et al, 1999;Fried et al, 1993;Spiegelman et al, 1993), and two glucose transporter molecules SLC2A3 and SLC2A14) could contribute to the switch of preosteoblasts into adipocytes during transdifferentiation. Furthermore, the initiation of transdifferentiation could involve other factors and signaling pathways that have not been described in the context of direct differentiation or whose functions have not been revealed so far.…”